Hoosier Cancer Research Network on Facebook

Hoosier Cancer Research Network on Facebook

OnCore Login
Login to Oncore Network

Login to Oncore Network

Hoosier Cancer Research Network on Facebook

Hoosier Cancer Research Network on Facebook

GI00-16

A Phase II Study of Cisplatin, 5-Fluorouracil (5-FU), Radiation Therapy and Celecoxib for Resectable Esophageal Cancer – HOG GI 00-16

Abstracts/Posters/Presentations:

  • R Govindan, N. Fineberg, H. McLeod, K. Kesler, N. Hanna, C. Stoner, J. Vinson, R. Mantravadi, L. Einhorn. A Phase II Study of Cisplatin, 5-Fluorouracil (5-FU), Radiation (RT) and Celecoxib in Patients with Resectable Esophageal Cancer (EC): Hoosier Oncology Group GI00-16. Accepted to the general poster session at the ASCO annual meeting June 5-8, 2004, New Orleans, LA.
  • Prasad Mantravadi MD, Naomi Fineberg PhD, Rafat Ansari MD, Edward Fox MD, Paul Helft MD, Kenneth Kesler MD, Nasser Hanna MD, Lawrence Einhorn MD, Cindy Stoner, Ramaswamy Govindan MD. A Phase II Study of Cisplatin, 5-Fluorouracil (5-FU), Radiation (RT) and Celecoxib in Patients with Resectable Esophageal Cancer (EC): Preliminary Results from the Hoosier Oncology Group: GI00-16. Poster presentation at the ASCO annual meeting May 31-June 3, 2003, Chicago, IL
  • R Govindan, N. Fineberg, H. McLeod, K. Kesler, N. Hanna, C.Stoner, J. Vinson, R. Mantravadi, L. Einhorn. A Phase II Study of Cisplatin, 5-Fluorouracil (5-FU), Radiation (RT) and Celecoxib in Patients with Resectable Esophageal Cancer (EC) Hoosier Oncology Group: GI00-16. Accepted to the ASCO annual meeting June 5-8, 2004, New Orleans, LA.

Manuscripts/Articles:

  • Prasad Mantravadi MD, Naomi Fineberg PhD, Rafat Ansari MD, Edward Fox MD, Paul Helft MD, Kenneth Kesler MD, Nasser Hanna MD, Lawrence Einhorn MD, Cindy Stoner, Ramaswamy Govindan MD. A Phase II Study of Cisplatin, 5-Fluorouracil (5-FU), Radiation (RT) and Celecoxib in Patients with Resectable Esophageal Cancer (EC): Preliminary Results from the Hoosier Oncology Group: GI00-16. Supplement Oncology News International, October 2003.